FDA cGMP Inspection Readiness: A Practical Checklist for Supplement Brands

For dietary supplement brands selling in the United States, an FDA inspection is not a matter of if but when. Facilities registered with the FDA are subject to routine cGMP inspections under 21 CFR Part 111, and inspectors can arrive with little or no advance notice. Whether you operate your own facility or work with a contract manufacturer, understanding inspection readiness protects your supply chain, your reputation, and your ability to keep selling.

What Is an FDA cGMP Inspection?

FDA investigators examine whether a manufacturing site follows current Good Manufacturing Practices for dietary supplements. The inspection covers the full quality system: personnel training, facility and equipment controls, raw material qualification, production and process controls, laboratory testing, packaging and labeling operations, complaint handling, and recordkeeping.

Inspections typically follow a documented protocol, and investigators request records on the spot. The outcome may be a "no action indicated" classification, a voluntary action indicated letter, or, in serious cases, a warning letter with mandated corrections.

Common Inspection Findings

Reviewing publicly available warning letters reveals recurring themes:

• Incomplete specifications: Missing or outdated specifications for components, in-process materials, or finished products.
• Insufficient testing: Failure to verify identity of every dietary ingredient, or skipping required finished-product testing.
• Documentation gaps: Batch records that are incomplete, back-dated, or lack signatures and timestamps.
• Inadequate investigations: Complaints and deviations closed without root-cause analysis.
• Facility and equipment issues: Poor sanitation, uncalibrated instruments, or inadequate environmental controls.

Pre-Inspection Readiness Checklist

Documentation Review

Facility and Equipment

• Sanitation program: Written cleaning procedures for equipment and facility areas, with logs proving execution.
• Calibration program: Scheduled calibration of scales, pH meters, dissolution apparatus, and environmental monitors.
• Environmental controls: Documented temperature, humidity, and air quality management, including cleanroom certification where applicable.
• Pest control and water systems: Current service records and water quality testing results.

Quality Systems

• Laboratory operations: Identity testing on every incoming dietary ingredient, plus appropriate assays for potency, contaminants, and microbiological limits.
• Deviation and CAPA process: A functioning corrective and preventive action system with tracked root causes and effectiveness checks.
• Complaint handling: Logged consumer complaints with investigation records and trend analysis.
• Recall readiness: A written recall procedure and evidence of at least one mock recall exercise.

During the Inspection: What to Expect

An investigator will hold an opening meeting, tour the facility, review records, and conduct a closing meeting. Best practices during the inspection include designating a single point of contact, providing accurate copies rather than originals, keeping a detailed log of everything shared, and never guessing at answers. If a document does not exist, say so plainly rather than improvising.

How Brands Can Verify Their Contract Manufacturer

If you outsource production, your brand still carries reputational and, in some cases, regulatory exposure. Ask prospective or current partners for:

• FDA registration confirmation: The facility's registration status under the Bioterrorism Act and Food Safety Modernization Act requirements.
• Recent inspection history: Willingness to share inspection outcomes and any Form 483 observations with responses.
• Third-party audits: Certifications such as cGMP audits from recognized organizations.
• Sample batch records: Redacted records demonstrating documentation discipline.
• Testing transparency: Certificates of Analysis for your specific batches, with in-house and third-party verification.

Post-Inspection Actions

After any inspection or audit, review findings promptly, assign owners and deadlines to each observation, and document corrective actions with evidence of effectiveness. Respond to FDA observations within the expected timeframe, typically fifteen working days for Form 483 responses, and track commitments through to closure.

The Bottom Line

Inspection readiness is not a project; it is a state of continuous compliance. Brands that maintain current documentation, verify their manufacturing partners, and treat deviations as improvement opportunities move through inspections with minimal disruption. Working with an FDA-registered, cGMP-certified contract manufacturer that operates in-house testing and ISO 7 cleanroom production gives brands a structural advantage when regulators come knocking.